Publication date: Jul 03, 2026
A comment on Wagley et al. ‘s study of post-surgical outcomes in COVID-19 patients in Karachi, highlighting the importance of incorporating COVID-19 severity, timing of surgery, and maternal/fetal outcomes. These considerations can improve perioperative risk assessment and inform resource allocation in low- and middle-income countries.
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | Infectious Diseases |
| drug | DRUGBANK | Coenzyme M |
| pathway | REACTOME | Reproduction |
| disease | MESH | included |
| disease | MESH | face |
| drug | DRUGBANK | Pentaerythritol tetranitrate |
| disease | MESH | infection |
| drug | DRUGBANK | Oxygen |
| disease | MESH | dis |
| disease | MESH | emergency |
| disease | MESH | Long COVID |
| disease | MESH | inflammation |
| disease | MESH | fever |
| drug | DRUGBANK | Guanosine |
| drug | DRUGBANK | Carboxyamidotriazole |
Original Article
(Visited 3 times, 1 visits today)